Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme

478
72
Favorite

Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme

Bloomberg2021-06-23

Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing. Orphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

478

Report

Comment（72）

G3113
·2021-06-24
?
Reply
Like
Report
Fold Replies
- G3113:
  ?
  2021-06-25
  Reply
  Report
- G3113:
  ?
  2021-06-25
  Reply
  Report
Takiho
·2021-06-24
Goldman Sach - good to look at, promising share
Reply
Like
Report
Radedward
·2021-06-24
It’s fine when banks do it but suspicious when reddit groups try?
Reply
Like
Report
Fold Replies
- CSYNCTP06:
  Hi
  2021-06-24
  Reply
  Report
bzlim
·2021-06-24
Most definitely contributed to the soar that day but also contributed to the crash. Also known as pump and dump.
Reply
Like
Report
SPOT_ON
·2021-06-24
Power
Reply
1
Report
eric2211
·2021-06-24
Nice
Reply
1
Report
chyoli
·2021-06-24
hi
Reply
1
Report
FreePrincess
·2021-06-24
Ok. Please reply to my comment. Thank you.
Reply
7
Report
Fold Replies
- Couragesther:
  Replt too
  2021-06-24
  Reply
  Report
- Kenang:
  Ok
  2021-06-24
  Reply
  Report
- JeffreyNeo:
  1
  2021-06-24
  Reply
  Report
堵神
·2021-06-24
Please like and comment thanks ☺️
Reply
4
Report
Fold Replies
- FreePrincess:
  Done
  2021-06-24
  Reply
  Report
- T2C:
  Yes
  2021-06-24
  Reply
  Report
NPC69
·2021-06-24
Like
Reply
5
Report
Fold Replies
- DLiew:
  Like and comment
  2021-06-24
  Reply
  Report
Lim89
·2021-06-24
Nice
Reply
4
Report
Fold Replies
- Lim89:
  Ya
  2021-06-24
  Reply
  Report
Mitchu
·2021-06-24
Ok
Reply
Like
Report
yangmehmeh
·2021-06-24
Lol
Reply
5
Report
Fold Replies
- yangmehmeh:
  Dump!
  2021-06-24
  Reply
  Report
StayHome
·2021-06-24
Pump and dump again?
Reply
4
Report
dian90
·2021-06-24
Gd view
Reply
Like
Report
dian90
·2021-06-24
Gd
Reply
Like
Report
Rozilla
·2021-06-24
Hmm
Reply
3
Report
1nu
·2021-06-24
help me like and comment :)
Reply
3
Report
Fold Replies
- AshpA:
  Commment
  2021-06-24
  Reply
  Report
Iamwilliam
·2021-06-24
What
Reply
1
Report
Fold Replies
- 1nu:
  help me like and comment :)
  2021-06-24
  Reply
  Report
J90
·2021-06-24
Hm
Reply
2
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1159107044?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-06-23 22:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1159107044","market":"us","top_or_hot":-1,"title":"Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme","media":"Bloomberg","content":"<div>\n<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp\">Source Link</a>\n\n</div>\n","source":"lsy1584095487587","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs Briefly Builds Stake in Meme Stock Orphazyme\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-23 22:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GS","symbol_name":"高盛","start_time":0,"source_url":"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp","article_id":"1159107044","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1159107044","pubTimestamp":1624459161,"columns":[],"sourceInfo":{"source_id":"lsy1584095487587","name":"Bloomberg"},"weMediaInfo":null,"summary":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according t","collect":0,"end_time":0,"defaultTopTitle":"bloomberg.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"GS":"高盛"},"translate_title":"高盛在迷因股票Orphazyme中短暂建股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GS":0.9},"content_text":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.\n\nGoldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.\nOrphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":128111734,"gmtCreate":1624505583628,"gmtModify":1703838672667,"author":{"id":"3573191001665366","authorId":"3573191001665366","name":"G3113","avatar":"https://community-static.tradeup.com/news/9871a22da6d58de3e699d77467b37730","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":3,"crmLevelSwitch":1,"authorIdStr":"3573191001665366","idStr":"3573191001665366"},"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/128111734","repostId":1159107044,"repostType":4,"repost":{"id":"1159107044","kind":"news","pubTimestamp":1624459161,"share":"https://ttm.financial/m/news/1159107044?lang=&edition=fundamental","pubTime":"2021-06-23 22:39","market":"us","language":"en","title":"Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme","url":"https://stock-news.laohu8.com/highlight/detail?id=1159107044","media":"Bloomberg","summary":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according t","content":"<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.</p>\n<p>Orphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.</p>\n<p><img src=\"https://static.tigerbbs.com/87c5b53a8732ab8cba47ac53ffda357d\" tg-width=\"558\" tg-height=\"313\" referrerpolicy=\"no-referrer\"></p>\n<p>Goldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.</p>\n<p>Orphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs Briefly Builds Stake in Meme Stock Orphazyme\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-23 22:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GS":"高盛"},"source_url":"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159107044","content_text":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.\n\nGoldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.\nOrphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5009166,"gmtCreate":1624597745233,"gmtModify":1663229981531,"authorId":3573191001665366,"author":{"id":3573191001665366,"idStr":"3573191001665366","authorId":3573191001665366,"name":"G3113","avatar":"https://community-static.tradeup.com/news/9871a22da6d58de3e699d77467b37730","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.08.31","exceedPercentage":"80.92%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":3,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":128111734,"type":1,"supId":0,"prevId":0,"content":"?","text":"?","html":"?"},{"id":5009528,"gmtCreate":1624599681392,"gmtModify":1663229980643,"authorId":3573191001665366,"author":{"id":3573191001665366,"idStr":"3573191001665366","authorId":3573191001665366,"name":"G3113","avatar":"https://community-static.tradeup.com/news/9871a22da6d58de3e699d77467b37730","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.08.31","exceedPercentage":"80.92%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":3,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":128111734,"type":1,"supId":0,"prevId":0,"content":"?","text":"?","html":"?"}],"langContent":"EN"},{"id":121744666,"gmtCreate":1624493887155,"gmtModify":1703838179286,"author":{"id":"3586588423230446","authorId":"3586588423230446","name":"Takiho","avatar":"https://static.tigerbbs.com/9c71ba836ffdebd7c9d6c75d4b188cd8","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3586588423230446","idStr":"3586588423230446"},"htmlText":"Goldman Sach - good to look at, promising share&nbsp;","listText":"Goldman Sach - good to look at, promising share&nbsp;","text":"Goldman Sach - good to look at, promising share","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/121744666","repostId":1159107044,"repostType":4,"repost":{"id":"1159107044","kind":"news","pubTimestamp":1624459161,"share":"https://ttm.financial/m/news/1159107044?lang=&edition=fundamental","pubTime":"2021-06-23 22:39","market":"us","language":"en","title":"Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme","url":"https://stock-news.laohu8.com/highlight/detail?id=1159107044","media":"Bloomberg","summary":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according t","content":"<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.</p>\n<p>Orphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.</p>\n<p><img src=\"https://static.tigerbbs.com/87c5b53a8732ab8cba47ac53ffda357d\" tg-width=\"558\" tg-height=\"313\" referrerpolicy=\"no-referrer\"></p>\n<p>Goldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.</p>\n<p>Orphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs Briefly Builds Stake in Meme Stock Orphazyme\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-23 22:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GS":"高盛"},"source_url":"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159107044","content_text":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.\n\nGoldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.\nOrphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":121751950,"gmtCreate":1624493433670,"gmtModify":1703838157774,"author":{"id":"3586585894056979","authorId":"3586585894056979","name":"Radedward","avatar":"https://static.tigerbbs.com/2f0517067d18531fa857b594c9650d99","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3586585894056979","idStr":"3586585894056979"},"htmlText":"It’s fine when banks do it but suspicious when reddit groups try?","listText":"It’s fine when banks do it but suspicious when reddit groups try?","text":"It’s fine when banks do it but suspicious when reddit groups try?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/121751950","repostId":1159107044,"repostType":4,"repost":{"id":"1159107044","kind":"news","pubTimestamp":1624459161,"share":"https://ttm.financial/m/news/1159107044?lang=&edition=fundamental","pubTime":"2021-06-23 22:39","market":"us","language":"en","title":"Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme","url":"https://stock-news.laohu8.com/highlight/detail?id=1159107044","media":"Bloomberg","summary":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according t","content":"<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.</p>\n<p>Orphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.</p>\n<p><img src=\"https://static.tigerbbs.com/87c5b53a8732ab8cba47ac53ffda357d\" tg-width=\"558\" tg-height=\"313\" referrerpolicy=\"no-referrer\"></p>\n<p>Goldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.</p>\n<p>Orphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs Briefly Builds Stake in Meme Stock Orphazyme\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-23 22:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GS":"高盛"},"source_url":"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159107044","content_text":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.\n\nGoldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.\nOrphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4985995,"gmtCreate":1624497234054,"gmtModify":1663229865840,"authorId":3569978586500313,"author":{"id":3569978586500313,"idStr":"3569978586500313","authorId":3569978586500313,"name":"CSYNCTP06","avatar":"https://community-static.tradeup.com/news/8cb958ad8c93ebca5e9a5127b15fe945","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":121751950,"type":1,"supId":0,"prevId":0,"content":"Hi","text":"Hi","html":"Hi"}],"langContent":"EN"},{"id":121788140,"gmtCreate":1624492574280,"gmtModify":1703838117850,"author":{"id":"3572436349218639","authorId":"3572436349218639","name":"bzlim","avatar":"https://static.tigerbbs.com/3b2aafaf14823285f7393917b6ff4f54","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3572436349218639","idStr":"3572436349218639"},"htmlText":"Most definitely contributed to the soar that day but also contributed to the crash. Also known as pump and dump.&nbsp;","listText":"Most definitely contributed to the soar that day but also contributed to the crash. Also known as pump and dump.&nbsp;","text":"Most definitely contributed to the soar that day but also contributed to the crash. Also known as pump and dump.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/121788140","repostId":1159107044,"repostType":4,"repost":{"id":"1159107044","kind":"news","pubTimestamp":1624459161,"share":"https://ttm.financial/m/news/1159107044?lang=&edition=fundamental","pubTime":"2021-06-23 22:39","market":"us","language":"en","title":"Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme","url":"https://stock-news.laohu8.com/highlight/detail?id=1159107044","media":"Bloomberg","summary":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according t","content":"<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.</p>\n<p>Orphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.</p>\n<p><img src=\"https://static.tigerbbs.com/87c5b53a8732ab8cba47ac53ffda357d\" tg-width=\"558\" tg-height=\"313\" referrerpolicy=\"no-referrer\"></p>\n<p>Goldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.</p>\n<p>Orphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs Briefly Builds Stake in Meme Stock Orphazyme\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-23 22:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GS":"高盛"},"source_url":"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159107044","content_text":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.\n\nGoldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.\nOrphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":121716792,"gmtCreate":1624492352916,"gmtModify":1703838106045,"author":{"id":"3582922989777578","authorId":"3582922989777578","name":"SPOT_ON","avatar":"https://static.tigerbbs.com/080f029371339d9db26930961de6adb1","vip":1,"hat":"https://static.tigerbbs.com/a3dee1aa3a3a3c1814833a4d3f8a5669","crmLevel":4,"crmLevelSwitch":1,"authorIdStr":"3582922989777578","idStr":"3582922989777578"},"htmlText":"Power","listText":"Power","text":"Power","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/121716792","repostId":1159107044,"repostType":4,"repost":{"id":"1159107044","kind":"news","pubTimestamp":1624459161,"share":"https://ttm.financial/m/news/1159107044?lang=&edition=fundamental","pubTime":"2021-06-23 22:39","market":"us","language":"en","title":"Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme","url":"https://stock-news.laohu8.com/highlight/detail?id=1159107044","media":"Bloomberg","summary":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according t","content":"<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.</p>\n<p>Orphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.</p>\n<p><img src=\"https://static.tigerbbs.com/87c5b53a8732ab8cba47ac53ffda357d\" tg-width=\"558\" tg-height=\"313\" referrerpolicy=\"no-referrer\"></p>\n<p>Goldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.</p>\n<p>Orphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs Briefly Builds Stake in Meme Stock Orphazyme\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-23 22:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GS":"高盛"},"source_url":"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159107044","content_text":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.\n\nGoldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.\nOrphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":121458195,"gmtCreate":1624490516917,"gmtModify":1703838020669,"author":{"id":"3587085550299233","authorId":"3587085550299233","name":"eric2211","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3587085550299233","idStr":"3587085550299233"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/121458195","repostId":1159107044,"repostType":4,"repost":{"id":"1159107044","kind":"news","pubTimestamp":1624459161,"share":"https://ttm.financial/m/news/1159107044?lang=&edition=fundamental","pubTime":"2021-06-23 22:39","market":"us","language":"en","title":"Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme","url":"https://stock-news.laohu8.com/highlight/detail?id=1159107044","media":"Bloomberg","summary":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according t","content":"<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.</p>\n<p>Orphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.</p>\n<p><img src=\"https://static.tigerbbs.com/87c5b53a8732ab8cba47ac53ffda357d\" tg-width=\"558\" tg-height=\"313\" referrerpolicy=\"no-referrer\"></p>\n<p>Goldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.</p>\n<p>Orphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs Briefly Builds Stake in Meme Stock Orphazyme\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-23 22:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GS":"高盛"},"source_url":"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159107044","content_text":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.\n\nGoldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.\nOrphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":121459475,"gmtCreate":1624490477097,"gmtModify":1703838017436,"author":{"id":"3581496383984056","authorId":"3581496383984056","name":"chyoli","avatar":"https://static.tigerbbs.com/54352365cc1ad4b9aa7d1e0c9bb8663d","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3581496383984056","idStr":"3581496383984056"},"htmlText":"hi","listText":"hi","text":"hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/121459475","repostId":1159107044,"repostType":4,"repost":{"id":"1159107044","kind":"news","pubTimestamp":1624459161,"share":"https://ttm.financial/m/news/1159107044?lang=&edition=fundamental","pubTime":"2021-06-23 22:39","market":"us","language":"en","title":"Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme","url":"https://stock-news.laohu8.com/highlight/detail?id=1159107044","media":"Bloomberg","summary":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according t","content":"<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.</p>\n<p>Orphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.</p>\n<p><img src=\"https://static.tigerbbs.com/87c5b53a8732ab8cba47ac53ffda357d\" tg-width=\"558\" tg-height=\"313\" referrerpolicy=\"no-referrer\"></p>\n<p>Goldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.</p>\n<p>Orphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs Briefly Builds Stake in Meme Stock Orphazyme\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-23 22:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GS":"高盛"},"source_url":"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159107044","content_text":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.\n\nGoldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.\nOrphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":121464861,"gmtCreate":1624489995053,"gmtModify":1703837999708,"author":{"id":"3582347714998199","authorId":"3582347714998199","name":"FreePrincess","avatar":"https://static.tigerbbs.com/e5875e48241b7c20bf1855e00a4224eb","vip":1,"crmLevel":6,"crmLevelSwitch":0,"authorIdStr":"3582347714998199","idStr":"3582347714998199"},"htmlText":"Ok. Please reply to my comment. Thank you.&nbsp;","listText":"Ok. Please reply to my comment. Thank you.&nbsp;","text":"Ok. Please reply to my comment. Thank you.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/121464861","repostId":1159107044,"repostType":4,"repost":{"id":"1159107044","kind":"news","pubTimestamp":1624459161,"share":"https://ttm.financial/m/news/1159107044?lang=&edition=fundamental","pubTime":"2021-06-23 22:39","market":"us","language":"en","title":"Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme","url":"https://stock-news.laohu8.com/highlight/detail?id=1159107044","media":"Bloomberg","summary":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according t","content":"<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.</p>\n<p>Orphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.</p>\n<p><img src=\"https://static.tigerbbs.com/87c5b53a8732ab8cba47ac53ffda357d\" tg-width=\"558\" tg-height=\"313\" referrerpolicy=\"no-referrer\"></p>\n<p>Goldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.</p>\n<p>Orphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs Briefly Builds Stake in Meme Stock Orphazyme\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-23 22:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GS":"高盛"},"source_url":"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159107044","content_text":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.\n\nGoldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.\nOrphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4983197,"gmtCreate":1624490547050,"gmtModify":1663229853930,"authorId":3557433279201512,"author":{"id":3557433279201512,"idStr":"3557433279201512","authorId":3557433279201512,"name":"Couragesther","avatar":"https://static.tigerbbs.com/fb776fde22322bb11f3651d216a6b06e","vip":1,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.09.09","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1001},"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":121464861,"type":1,"supId":0,"prevId":0,"content":"Replt too","text":"Replt too","html":"Replt too"},{"id":4982987,"gmtCreate":1624490011469,"gmtModify":1663229852927,"authorId":3578783239633074,"author":{"id":3578783239633074,"idStr":"3578783239633074","authorId":3578783239633074,"name":"Kenang","avatar":"https://static.tigerbbs.com/9b932623d314153a412ec6160f17873c","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":121464861,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"},{"id":4983140,"gmtCreate":1624490467833,"gmtModify":1663229852850,"authorId":3581919031797456,"author":{"id":3581919031797456,"idStr":"3581919031797456","authorId":3581919031797456,"name":"JeffreyNeo","avatar":"https://static.tigerbbs.com/fd016aa2ec66a904f877445461310e24","vip":1,"crmLevel":2,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":121464861,"type":1,"supId":4982987,"prevId":0,"content":"<u>1</u>","text":"<u>1</u>","html":"<u>1</u>"}],"langContent":"EN"},{"id":121460897,"gmtCreate":1624489667519,"gmtModify":1703837989528,"author":{"id":"3569643178216945","authorId":"3569643178216945","name":"堵神","avatar":"https://static.tigerbbs.com/cacee5ba5c333e51bfcd4bed94dada85","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3569643178216945","idStr":"3569643178216945"},"htmlText":"Please like and comment thanks ☺️","listText":"Please like and comment thanks ☺️","text":"Please like and comment thanks ☺️","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/121460897","repostId":1159107044,"repostType":4,"repost":{"id":"1159107044","kind":"news","pubTimestamp":1624459161,"share":"https://ttm.financial/m/news/1159107044?lang=&edition=fundamental","pubTime":"2021-06-23 22:39","market":"us","language":"en","title":"Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme","url":"https://stock-news.laohu8.com/highlight/detail?id=1159107044","media":"Bloomberg","summary":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according t","content":"<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.</p>\n<p>Orphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.</p>\n<p><img src=\"https://static.tigerbbs.com/87c5b53a8732ab8cba47ac53ffda357d\" tg-width=\"558\" tg-height=\"313\" referrerpolicy=\"no-referrer\"></p>\n<p>Goldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.</p>\n<p>Orphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs Briefly Builds Stake in Meme Stock Orphazyme\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-23 22:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GS":"高盛"},"source_url":"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159107044","content_text":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.\n\nGoldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.\nOrphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4982985,"gmtCreate":1624490007109,"gmtModify":1663229853025,"authorId":3582347714998199,"author":{"id":3582347714998199,"idStr":"3582347714998199","authorId":3582347714998199,"name":"FreePrincess","avatar":"https://static.tigerbbs.com/e5875e48241b7c20bf1855e00a4224eb","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":121460897,"type":1,"supId":0,"prevId":0,"content":"Done  ","text":"Done  ","html":"Done  "},{"id":4982936,"gmtCreate":1624489794831,"gmtModify":1635249487811,"authorId":3576917742134919,"author":{"id":3576917742134919,"idStr":"3576917742134919","authorId":3576917742134919,"name":"T2C","avatar":"https://static.itradeup.com/news/bc988e20e446d98ea284e01ce997a013","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":121460897,"type":1,"supId":0,"prevId":0,"content":"Yes","text":"Yes","html":"Yes"}],"langContent":"EN"},{"id":121486867,"gmtCreate":1624489473259,"gmtModify":1703837982513,"author":{"id":"3584779133668268","authorId":"3584779133668268","name":"NPC69","avatar":"https://static.tigerbbs.com/47e7ac55312ae8dd1c9e7cb92adad089","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3584779133668268","idStr":"3584779133668268"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/121486867","repostId":1159107044,"repostType":4,"repost":{"id":"1159107044","kind":"news","pubTimestamp":1624459161,"share":"https://ttm.financial/m/news/1159107044?lang=&edition=fundamental","pubTime":"2021-06-23 22:39","market":"us","language":"en","title":"Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme","url":"https://stock-news.laohu8.com/highlight/detail?id=1159107044","media":"Bloomberg","summary":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according t","content":"<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.</p>\n<p>Orphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.</p>\n<p><img src=\"https://static.tigerbbs.com/87c5b53a8732ab8cba47ac53ffda357d\" tg-width=\"558\" tg-height=\"313\" referrerpolicy=\"no-referrer\"></p>\n<p>Goldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.</p>\n<p>Orphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs Briefly Builds Stake in Meme Stock Orphazyme\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-23 22:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GS":"高盛"},"source_url":"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159107044","content_text":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.\n\nGoldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.\nOrphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4983237,"gmtCreate":1624490644632,"gmtModify":1663229852736,"authorId":3577525278195004,"author":{"id":3577525278195004,"idStr":"3577525278195004","authorId":3577525278195004,"name":"DLiew","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":121486867,"type":1,"supId":0,"prevId":0,"content":"Like and <u>comment</u>","text":"Like and <u>comment</u>","html":"Like and <u>comment</u>"}],"langContent":"EN"},{"id":121483351,"gmtCreate":1624489349773,"gmtModify":1703837977819,"author":{"id":"3527303552443900","authorId":"3527303552443900","name":"Lim89","avatar":"https://static.tigerbbs.com/f21e4020ff962f4d66f99662b584ec1c","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3527303552443900","idStr":"3527303552443900"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/121483351","repostId":1159107044,"repostType":4,"repost":{"id":"1159107044","kind":"news","pubTimestamp":1624459161,"share":"https://ttm.financial/m/news/1159107044?lang=&edition=fundamental","pubTime":"2021-06-23 22:39","market":"us","language":"en","title":"Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme","url":"https://stock-news.laohu8.com/highlight/detail?id=1159107044","media":"Bloomberg","summary":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according t","content":"<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.</p>\n<p>Orphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.</p>\n<p><img src=\"https://static.tigerbbs.com/87c5b53a8732ab8cba47ac53ffda357d\" tg-width=\"558\" tg-height=\"313\" referrerpolicy=\"no-referrer\"></p>\n<p>Goldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.</p>\n<p>Orphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs Briefly Builds Stake in Meme Stock Orphazyme\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-23 22:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GS":"高盛"},"source_url":"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159107044","content_text":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.\n\nGoldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.\nOrphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4982829,"gmtCreate":1624489436956,"gmtModify":1663229850126,"authorId":3527303552443900,"author":{"id":3527303552443900,"idStr":"3527303552443900","authorId":3527303552443900,"name":"Lim89","avatar":"https://static.tigerbbs.com/f21e4020ff962f4d66f99662b584ec1c","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":121483351,"type":1,"supId":0,"prevId":0,"content":"<u>Ya</u>","text":"<u>Ya</u>","html":"<u>Ya</u>"}],"langContent":"EN"},{"id":121414529,"gmtCreate":1624489223461,"gmtModify":1703837973117,"author":{"id":"3586931593498823","authorId":"3586931593498823","name":"Mitchu","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3586931593498823","idStr":"3586931593498823"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/121414529","repostId":1159107044,"repostType":4,"repost":{"id":"1159107044","kind":"news","pubTimestamp":1624459161,"share":"https://ttm.financial/m/news/1159107044?lang=&edition=fundamental","pubTime":"2021-06-23 22:39","market":"us","language":"en","title":"Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme","url":"https://stock-news.laohu8.com/highlight/detail?id=1159107044","media":"Bloomberg","summary":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according t","content":"<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.</p>\n<p>Orphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.</p>\n<p><img src=\"https://static.tigerbbs.com/87c5b53a8732ab8cba47ac53ffda357d\" tg-width=\"558\" tg-height=\"313\" referrerpolicy=\"no-referrer\"></p>\n<p>Goldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.</p>\n<p>Orphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs Briefly Builds Stake in Meme Stock Orphazyme\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-23 22:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GS":"高盛"},"source_url":"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159107044","content_text":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.\n\nGoldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.\nOrphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":121410839,"gmtCreate":1624488762621,"gmtModify":1703837961022,"author":{"id":"3574468336320831","authorId":"3574468336320831","name":"yangmehmeh","avatar":"https://static.tigerbbs.com/23b89d5a0acbdb3dac0211c8eea5acb3","vip":1,"crmLevel":6,"crmLevelSwitch":0,"authorIdStr":"3574468336320831","idStr":"3574468336320831"},"htmlText":"Lol","listText":"Lol","text":"Lol","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/121410839","repostId":1159107044,"repostType":4,"repost":{"id":"1159107044","kind":"news","pubTimestamp":1624459161,"share":"https://ttm.financial/m/news/1159107044?lang=&edition=fundamental","pubTime":"2021-06-23 22:39","market":"us","language":"en","title":"Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme","url":"https://stock-news.laohu8.com/highlight/detail?id=1159107044","media":"Bloomberg","summary":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according t","content":"<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.</p>\n<p>Orphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.</p>\n<p><img src=\"https://static.tigerbbs.com/87c5b53a8732ab8cba47ac53ffda357d\" tg-width=\"558\" tg-height=\"313\" referrerpolicy=\"no-referrer\"></p>\n<p>Goldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.</p>\n<p>Orphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs Briefly Builds Stake in Meme Stock Orphazyme\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-23 22:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GS":"高盛"},"source_url":"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159107044","content_text":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.\n\nGoldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.\nOrphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4982675,"gmtCreate":1624488778793,"gmtModify":1663229853146,"authorId":3574468336320831,"author":{"id":3574468336320831,"idStr":"3574468336320831","authorId":3574468336320831,"name":"yangmehmeh","avatar":"https://static.tigerbbs.com/23b89d5a0acbdb3dac0211c8eea5acb3","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":121410839,"type":1,"supId":0,"prevId":0,"content":"Dump!","text":"Dump!","html":"Dump!"}],"langContent":"EN"},{"id":121433007,"gmtCreate":1624488243109,"gmtModify":1703837949361,"author":{"id":"3586303845668227","authorId":"3586303845668227","name":"StayHome","avatar":"https://static.tigerbbs.com/a2090cc80fca211990d8fc4e216f75b7","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3586303845668227","idStr":"3586303845668227"},"htmlText":"Pump and dump again?","listText":"Pump and dump again?","text":"Pump and dump again?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/121433007","repostId":1159107044,"repostType":4,"repost":{"id":"1159107044","kind":"news","pubTimestamp":1624459161,"share":"https://ttm.financial/m/news/1159107044?lang=&edition=fundamental","pubTime":"2021-06-23 22:39","market":"us","language":"en","title":"Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme","url":"https://stock-news.laohu8.com/highlight/detail?id=1159107044","media":"Bloomberg","summary":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according t","content":"<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.</p>\n<p>Orphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.</p>\n<p><img src=\"https://static.tigerbbs.com/87c5b53a8732ab8cba47ac53ffda357d\" tg-width=\"558\" tg-height=\"313\" referrerpolicy=\"no-referrer\"></p>\n<p>Goldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.</p>\n<p>Orphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs Briefly Builds Stake in Meme Stock Orphazyme\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-23 22:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GS":"高盛"},"source_url":"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159107044","content_text":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.\n\nGoldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.\nOrphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":121430621,"gmtCreate":1624488119463,"gmtModify":1703837947093,"author":{"id":"3586925802966561","authorId":"3586925802966561","name":"dian90","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3586925802966561","idStr":"3586925802966561"},"htmlText":"Gd view","listText":"Gd view","text":"Gd view","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/121430621","repostId":1159107044,"repostType":4,"repost":{"id":"1159107044","kind":"news","pubTimestamp":1624459161,"share":"https://ttm.financial/m/news/1159107044?lang=&edition=fundamental","pubTime":"2021-06-23 22:39","market":"us","language":"en","title":"Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme","url":"https://stock-news.laohu8.com/highlight/detail?id=1159107044","media":"Bloomberg","summary":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according t","content":"<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.</p>\n<p>Orphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.</p>\n<p><img src=\"https://static.tigerbbs.com/87c5b53a8732ab8cba47ac53ffda357d\" tg-width=\"558\" tg-height=\"313\" referrerpolicy=\"no-referrer\"></p>\n<p>Goldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.</p>\n<p>Orphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs Briefly Builds Stake in Meme Stock Orphazyme\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-23 22:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GS":"高盛"},"source_url":"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159107044","content_text":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.\n\nGoldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.\nOrphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":121497140,"gmtCreate":1624488027780,"gmtModify":1703837945958,"author":{"id":"3586925802966561","authorId":"3586925802966561","name":"dian90","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3586925802966561","idStr":"3586925802966561"},"htmlText":"Gd","listText":"Gd","text":"Gd","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/121497140","repostId":1159107044,"repostType":4,"repost":{"id":"1159107044","kind":"news","pubTimestamp":1624459161,"share":"https://ttm.financial/m/news/1159107044?lang=&edition=fundamental","pubTime":"2021-06-23 22:39","market":"us","language":"en","title":"Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme","url":"https://stock-news.laohu8.com/highlight/detail?id=1159107044","media":"Bloomberg","summary":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according t","content":"<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.</p>\n<p>Orphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.</p>\n<p><img src=\"https://static.tigerbbs.com/87c5b53a8732ab8cba47ac53ffda357d\" tg-width=\"558\" tg-height=\"313\" referrerpolicy=\"no-referrer\"></p>\n<p>Goldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.</p>\n<p>Orphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs Briefly Builds Stake in Meme Stock Orphazyme\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-23 22:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GS":"高盛"},"source_url":"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159107044","content_text":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.\n\nGoldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.\nOrphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":121491329,"gmtCreate":1624487532261,"gmtModify":1703837936183,"author":{"id":"3584845497808923","authorId":"3584845497808923","name":"Rozilla","avatar":"https://static.tigerbbs.com/48a6d0bfd53f17c7b4cd754a4ca13cc6","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3584845497808923","idStr":"3584845497808923"},"htmlText":"Hmm","listText":"Hmm","text":"Hmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/121491329","repostId":1159107044,"repostType":4,"repost":{"id":"1159107044","kind":"news","pubTimestamp":1624459161,"share":"https://ttm.financial/m/news/1159107044?lang=&edition=fundamental","pubTime":"2021-06-23 22:39","market":"us","language":"en","title":"Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme","url":"https://stock-news.laohu8.com/highlight/detail?id=1159107044","media":"Bloomberg","summary":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according t","content":"<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.</p>\n<p>Orphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.</p>\n<p><img src=\"https://static.tigerbbs.com/87c5b53a8732ab8cba47ac53ffda357d\" tg-width=\"558\" tg-height=\"313\" referrerpolicy=\"no-referrer\"></p>\n<p>Goldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.</p>\n<p>Orphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs Briefly Builds Stake in Meme Stock Orphazyme\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-23 22:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GS":"高盛"},"source_url":"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159107044","content_text":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.\n\nGoldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.\nOrphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":121499750,"gmtCreate":1624487448970,"gmtModify":1703837933900,"author":{"id":"3577610430427001","authorId":"3577610430427001","name":"1nu","avatar":"https://static.tigerbbs.com/15789a74f3eb14371af59c44a8f71041","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3577610430427001","idStr":"3577610430427001"},"htmlText":"help me like and comment :)","listText":"help me like and comment :)","text":"help me like and comment :)","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/121499750","repostId":1159107044,"repostType":4,"repost":{"id":"1159107044","kind":"news","pubTimestamp":1624459161,"share":"https://ttm.financial/m/news/1159107044?lang=&edition=fundamental","pubTime":"2021-06-23 22:39","market":"us","language":"en","title":"Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme","url":"https://stock-news.laohu8.com/highlight/detail?id=1159107044","media":"Bloomberg","summary":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according t","content":"<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.</p>\n<p>Orphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.</p>\n<p><img src=\"https://static.tigerbbs.com/87c5b53a8732ab8cba47ac53ffda357d\" tg-width=\"558\" tg-height=\"313\" referrerpolicy=\"no-referrer\"></p>\n<p>Goldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.</p>\n<p>Orphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs Briefly Builds Stake in Meme Stock Orphazyme\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-23 22:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GS":"高盛"},"source_url":"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159107044","content_text":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.\n\nGoldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.\nOrphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4982502,"gmtCreate":1624488060605,"gmtModify":1663229851228,"authorId":3578108806350933,"author":{"id":3578108806350933,"idStr":"3578108806350933","authorId":3578108806350933,"name":"AshpA","avatar":"https://static.tigerbbs.com/a5b86ba1440c9c7ae3bf77c5b39fd332","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":121499750,"type":1,"supId":0,"prevId":0,"content":"Commment","text":"Commment","html":"Commment"}],"langContent":"EN"},{"id":121407935,"gmtCreate":1624487260127,"gmtModify":1703837930338,"author":{"id":"3558205612679306","authorId":"3558205612679306","name":"Iamwilliam","avatar":"https://static.tigerbbs.com/e7373e3ef1ae972ffe6855bebcb227c3","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3558205612679306","idStr":"3558205612679306"},"htmlText":"What","listText":"What","text":"What","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/121407935","repostId":1159107044,"repostType":4,"repost":{"id":"1159107044","kind":"news","pubTimestamp":1624459161,"share":"https://ttm.financial/m/news/1159107044?lang=&edition=fundamental","pubTime":"2021-06-23 22:39","market":"us","language":"en","title":"Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme","url":"https://stock-news.laohu8.com/highlight/detail?id=1159107044","media":"Bloomberg","summary":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according t","content":"<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.</p>\n<p>Orphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.</p>\n<p><img src=\"https://static.tigerbbs.com/87c5b53a8732ab8cba47ac53ffda357d\" tg-width=\"558\" tg-height=\"313\" referrerpolicy=\"no-referrer\"></p>\n<p>Goldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.</p>\n<p>Orphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs Briefly Builds Stake in Meme Stock Orphazyme\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-23 22:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GS":"高盛"},"source_url":"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159107044","content_text":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.\n\nGoldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.\nOrphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4982394,"gmtCreate":1624487441867,"gmtModify":1631889713450,"authorId":3577610430427001,"author":{"id":3577610430427001,"idStr":"3577610430427001","authorId":3577610430427001,"name":"1nu","avatar":"https://static.tigerbbs.com/15789a74f3eb14371af59c44a8f71041","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":121407935,"type":1,"supId":0,"prevId":0,"content":"help me like and comment :)","text":"help me like and comment :)","html":"help me like and comment :)"}],"langContent":"EN"},{"id":121401466,"gmtCreate":1624486888255,"gmtModify":1703837922897,"author":{"id":"3581487017513023","authorId":"3581487017513023","name":"J90","avatar":"https://static.tigerbbs.com/59b9bd5153d367d5ee88324bdf6c6003","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3581487017513023","idStr":"3581487017513023"},"htmlText":"Hm","listText":"Hm","text":"Hm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/121401466","repostId":1159107044,"repostType":4,"repost":{"id":"1159107044","kind":"news","pubTimestamp":1624459161,"share":"https://ttm.financial/m/news/1159107044?lang=&edition=fundamental","pubTime":"2021-06-23 22:39","market":"us","language":"en","title":"Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme","url":"https://stock-news.laohu8.com/highlight/detail?id=1159107044","media":"Bloomberg","summary":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according t","content":"<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.</p>\n<p>Orphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.</p>\n<p><img src=\"https://static.tigerbbs.com/87c5b53a8732ab8cba47ac53ffda357d\" tg-width=\"558\" tg-height=\"313\" referrerpolicy=\"no-referrer\"></p>\n<p>Goldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.</p>\n<p>Orphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs Briefly Builds Stake in Meme Stock Orphazyme\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-23 22:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GS":"高盛"},"source_url":"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159107044","content_text":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.\n\nGoldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.\nOrphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":478,"commentSize":72,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}